Hans Leuenberger

Articles in Scholarly Journals [Incomplete List]

  1. Percolation Theory and the Role of Maize Starch as a Disintegrant for a Low Water-Soluble Drug
    Pharmaceutical Development and Technology, vol. 12, no. 1, pp. 11–19, 2007
  2. Spray Freeze Drying in a Fluidized Bed at Normal and Low Pressure
    Drying Technology, vol. 24, no. 6, pp. 711–719, 2006
  3. Pharmaceutical Technology: Drug Delivery, Formulation, and Process Research
    CHIMIA International Journal for Chemistry, vol. 60, no. 1, pp. 40–45, 2006
  4. E-Learning and Development of New Courses and Scientific Work in the Field of Pharmaceutical Technology
    CHIMIA International Journal for Chemistry, vol. 60, no. 1, pp. 80–82, 2006
  5. Pharmaceutical powder technology — from art to science: the challenge of the FDA's Process Analytical Technology initiative
    Advanced Powder Technology, vol. 16, no. 1, pp. 3–25, 2005
  6. Preparation of Dry Powder Inhalation with Lactose Carrier Particles Surface-Coated Using a Wurster Fluidized Bed
    CHEMICAL & PHARMACEUTICAL BULLETIN, vol. 53, no. 4, pp. 431–434, 2005
  7. Modeling of Atmospheric Freeze Drying in a Spouted Bed
    Theoretical Foundations of Chemical Engineering, vol. 39, no. 6, pp. 594–598, 2005
  8. The characterization of aprotic polar liquids and percolation phenomena in DMSO/water mixtures
    European Journal of Pharmaceutics and Biopharmaceutics, vol. 61, no. 3, pp. 201–213, 2005
  9. Towards a better understanding of the parameter / in the characterization of polar liquids
    International Journal of Pharmaceutics, vol. 291, no. 1-2, pp. 189–195, 2005
  10. Detection of percolation phenomena in binary polar liquids by broadband dielectric spectroscopy
    International Journal of Pharmaceutics, vol. 291, no. 1-2, pp. 197–209, 2005
  11. In vivo comparison of various liposome formulations for cosmetic application
    International Journal of Pharmaceutics, vol. 296, no. 1-2, pp. 44–54, 2005
  12. Semicontinuous granulation—the process of choice for the production of pharmaceutical granules?
    Powder Technology, vol. 140, no. 3, pp. 163–168, 2004
  13. Preface
    Powder Technology, vol. 141, no. 3, p. 171, 2004
  14. Search for technological reasons to develop a capsule or a tablet formulation with respect to wettability and dissolution
    International Journal of Pharmaceutics, vol. 287, no. 1-2, pp. 135–145, 2004
  15. Power consumption measurement and temperature recording during granulation
    International Journal of Pharmaceutics, vol. 272, no. 1-2, pp. 137–149, 2004
  16. Comparative evaluation of the powder properties and compression behaviour of a new cellulose-based direct compression excipient and Avicel PH-102
    Journal of Pharmacy and Pharmacology, vol. 56, no. 8, pp. 951–956, 2004
  17. Aluminium in Over-the-Counter Drugs
    Drug Safety, vol. 26, no. 14, pp. 1011–1025, 2003
  18. Batch And Continuous Processing In The Production Of Pharmaceutical Granules#
    Pharmaceutical Development and Technology, vol. 8, no. 3, pp. 289–297, 2003
  19. Preparation of Dry Powder Inhalation by Surface Treatment of Lactose Carrier Particles
    CHEMICAL & PHARMACEUTICAL BULLETIN, vol. 51, no. 1, pp. 1–5, 2003
  20. Power consumption profile analysis and tensile strength measurements during moist agglomeration
    International Journal of Pharmaceutics, vol. 252, no. 1-2, pp. 11–25, 2003
  21. Compression behaviour of the enzyme ß-galactosidase and its mixture with microcrystalline cellulose
    International Journal of Pharmaceutics, vol. 260, no. 1, pp. 137–147, 2003
  22. Scale-up in the 4th dimension in the field of granulation and drying or how to avoid classical scale-up
    Powder Technology, vol. 130, no. 1-3, pp. 225–230, 2003
  23. A novel approach to the characterization of polar liquids. Part 2: binary mixtures
    International Journal of Pharmaceutics, vol. 241, no. 2, pp. 231–240, 2002
  24. Journal of Nanoparticle Research, vol. 4, no. 1/2, pp. 111–119, 2002
  25. A novel approach to the characterization of polar liquids Part 1: pure liquids
    International Journal of Pharmaceutics, vol. 225, no. 1-2, pp. 123–134, 2001
  26. New trends in the production of pharmaceutical granules: batch versus continuous processing
    European Journal of Pharmaceutics and Biopharmaceutics, vol. 52, no. 3, pp. 289–296, 2001
  27. New trends in the production of pharmaceutical granules: the classical batch concept and the problem of scale-up
    European Journal of Pharmaceutics and Biopharmaceutics, vol. 52, no. 3, pp. 279–288, 2001
  28. Evaluation of Flow Properties of Dry Powder Inhalation of Salbutamol Sulfate with Lactose Carrier.
    CHEMICAL & PHARMACEUTICAL BULLETIN, vol. 49, no. 10, pp. 1326–1330, 2001
  29. Thermal sterilization of heat-sensitive products using high-temperature short-time sterilization
    Journal of Pharmaceutical Sciences, vol. 90, no. 3, pp. 275–287, 2001
  30. A new model for the hardness of a compacted particle system, applied to tablets of pharmaceutical polymers
    Powder Technology, vol. 111, no. 1-2, pp. 145–153, 2000
  31. Pharmaceutical Research, vol. 17, no. 9, pp. 1118–1123, 2000
  32. A new theoretical approach to tablet strength of a binary mixture consisting of a well and a poorly compactable substance
    European Journal of Pharmaceutics and Biopharmaceutics, vol. 49, no. 2, pp. 151–159, 2000
  33. Pressure susceptibility of polymer tablets as a critical property: A modified heckel equation
    Journal of Pharmaceutical Sciences, vol. 88, no. 2, pp. 174–179, 1999
  34. Fracture in disordered media and tensile strength of microcrystalline cellulose tablets at low relative densities
    International Journal of Pharmaceutics, vol. 182, no. 2, pp. 243–255, 1999
  35. Percolation theory, conductivity and dissolution of hydrophilic suppository bases (PEG systems)
    International Journal of Pharmaceutics, vol. 189, no. 2, pp. 187–196, 1999
  36. Comparison of artificial neural networks (ANN) with classical modelling techniques using different experimental designs and data from a galenical study on a solid dosage form
    European Journal of Pharmaceutical Sciences, vol. 6, no. 4, pp. 287–300, 1998
  37. Pitfalls of artificial neural networks (ANN) modelling technique for data sets containing outlier measurements using a study on mixture properties of a direct compressed dosage form
    European Journal of Pharmaceutical Sciences, vol. 7, no. 1, pp. 17–28, 1998
  38. Advantages of Artificial Neural Networks (ANNs) as alternative modelling technique for data sets showing non-linear relationships using data from a galenical study on a solid dosage form
    European Journal of Pharmaceutical Sciences, vol. 7, no. 1, pp. 5–16, 1998
  39. Dissolution properties of praziquantel–PVP systems
    Pharmaceutica Acta Helvetiae, vol. 73, no. 2, pp. 89–94, 1998
  40. Vehicle-dependent in situ modification of membrane-controlled drug release
    Journal of Controlled Release, vol. 51, no. 1, pp. 23–34, 1998
  41. Percolation theory and physics of compression
    European Journal of Pharmaceutics and Biopharmaceutics, vol. 44, no. 3, pp. 269–272, 1997
  42. Pharmaceutical Research, vol. 14, no. 12, pp. 1706–1712, 1997
  43. Preparation of liposomes encapsulating water-soluble compounds using supercritical carbon dioxide
    Journal of Pharmaceutical Sciences, vol. 86, no. 8, pp. 921–928, 1997
  44. An improved diffusion cell design for determining drug transport parameters across cultured cell monolayers
    Journal of Pharmaceutical Sciences, vol. 85, no. 11, pp. 1196–1203, 1996
  45. Pharmaceutical Research, vol. 13, no. 1, pp. 32–37, 1996
  46. Zero-order release periods in inert matrices. Influence of the distance to the percolation threshold
    Pharmaceutica Acta Helvetiae, vol. 71, no. 5, pp. 335–339, 1996
  47. Study of percolation thresholds in ternary tablets
    International Journal of Pharmaceutics, vol. 139, no. 1-2, pp. 177–186, 1996
  48. Membrane modulated dissolution of oral drug delivery systems
    Pharmaceutica Acta Helvetiae, vol. 70, no. 2, pp. 117–124, 1995
  49. Percolation effects in matrix-type controlled drug release systems
    International Journal of Pharmaceutics, vol. 115, no. 2, pp. 217–224, 1995
  50. Modelling of drug release from polymer matrices: Effect of drug loading
    International Journal of Pharmaceutics, vol. 121, no. 2, pp. 141–148, 1995
  51. Wet spherical agglomeration of proteins as a new method to prepare parenteral fast soluble dosage forms
    International Journal of Pharmaceutics, vol. 101, no. 1-2, pp. 63–70, 1994
  52. Study of the release mechanism of carteolol inert matrix tablets on the basis of percolation theory
    International Journal of Pharmaceutics, vol. 109, no. 3, pp. 229–236, 1994
  53. Use of percolation theory to interpret water uptake, disintegration time and intrinsic dissolution rate of tablets consisting of binary mixtures
    Pharmaceutica Acta Helvetiae, vol. 69, no. 3, pp. 127–134, 1994
  54. Matrix type controlled release systems II. Percolation effects in non-swellable matrices
    Pharmaceutica Acta Helvetiae, vol. 68, no. 1, pp. 25–33, 1993
  55. The application of percolation theory to the compaction of pharmaceutical powders
    International Journal of Pharmaceutics, vol. 90, no. 3, pp. 213–219, 1993
  56. Formation of a tablet: A site and bond percolation phenomenon
    Journal of Pharmaceutical Sciences, vol. 81, no. 10, pp. 976–982, 1992
  57. The significance of slopes of the semilogarithmic relationship between hardness and solid fraction of porous compacts
    Powder Technology, vol. 64, no. 3, pp. 233–247, 1991
  58. Atmospheric spray-freeze drying: a suitable alternative in freeze-drying technology
    International Journal of Pharmaceutics, vol. 72, no. 2, pp. 97–110, 1991
  59. The effect of varying the composition of binary powder mixtures and compacts on their properties: A percolation phenomenon
    Powder Technology, vol. 60, no. 3, pp. 249–258, 1990
  60. Pharmaceutical Research, vol. 07, no. 2, pp. 113–117, 1990
  61. Agglomeration of binary mixtures in a high-speed mixer
    International Journal of Pharmaceutics, vol. 55, no. 2-3, pp. 135–141, 1989
  62. Effect of compression speed on the relationship between normalised solid fraction and mechanical properties of compacts
    International Journal of Pharmaceutics, vol. 57, no. 1, pp. R1–R5, 1989
  63. Relation between crushing strength and internal specific surface area of lactose compacts
    International Journal of Pharmaceutics, vol. 52, no. 2, pp. 91–100, 1989
  64. The relationship between solid fraction and mechanical properties of compacts — the percolation theory model approach
    International Journal of Pharmaceutics, vol. 46, no. 1-2, pp. 35–44, 1988
  65. Pharmaceutical Research, vol. 03, no. 2, pp. 65–74, 1986
  66. Pharmaceutical Research, vol. 03, no. 1, pp. 12–22, 1986
  67. Compression of binary powder mixtures and solubility parameters of solids
    International Journal of Pharmaceutics, vol. 27, no. 2-3, pp. 127–138, 1985
  68. Ueber das Komprimierverhalten von NaCl, KCl und Hexamethylentetramin
    Powder Technology, vol. 42, no. 2, pp. 137–144, 1985
  69. The compressibility and compactibility of powder systems
    International Journal of Pharmaceutics, vol. 12, no. 1, pp. 41–55, 1982
  70. Mathematische Modellierung und Optimierung pharmazeutisch-technologischer Qualitätsmerkmale fester Arzneiformen
    Pharmazie in Unserer Zeit, vol. 5, no. 3, pp. 65–76, 1976